REFERENCES
1. Gandhi J., Chen A., Dagur G., Suh Y., Smith N., Cali B., et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016; 215 (6): 704–11. DOI: https://doi.org/10.1016/j.ajog.2016.07.045 Epub 2016 Jul 26. PMID: 27472999.
2. Sadovsky R., Basson R., Krychman M., Morales A.M., Schover L., Wang R., et al. Cancer and sexual problems. J Sex Med. 2010; 7 (1 pt 2): 349–73. DOI: https://doi.org/10.1111/j.1743-6109.2009.01620.x
3. MacBride M.B., Rhodes D.J., Shuster L.T. Vulvovaginal atrophy. Mayo Clin Proc. 2010; 85 (1): 87–94. DOI: https://doi.org/10.4065/mcp.2009.0413 PMID: 20042564; PMCID: PMC2800285.
4. Wallace S.L., St Martin B., Lee K., Sokol E.R. A cost-effectiveness analysis of vaginal carbon dioxide laser therapy compared with standard medical therapies for genitourinary syndrome of menopause-associated dyspareunia. Am J Obstet Gynecol. 2020; 223 (6): 890.e1–12. DOI: https://doi.org/10.1016/j.ajog.2020.06.032 Epub 2020 Jun 17. PMID: 32562659.
5. Minkin M.J. Menopause: hormones, lifestyle, and optimizing aging. Obstet Gynecol Clin North Am. 2019; 46 (3): 501–14. DOI: https://doi.org/10.1016/j.ogc.2019.04.008 Epub 2019 Jun 21. PMID: 31378291.
6. Apolikhina I.A., Malyshkina D.A., Bychkova A.E., Pauzina O.A. Use of neodymium laser in the practice of an obstetrician/gynecologist. Akusherstvo i ginekologiya [Obstetrics and Gynecology]. 2021; (1): 194–9. DOI: https://doi.org/10.18565/aig.2021.1.194-199 (in Russian)
7. Mension E., Alonso I., Tortajada M., Matas I., Gómez S., Ribera L., et al. Vaginal laser therapy for genitourinary syndrome of menopause – systematic review. Maturitas. 2022; 156: 37–59. DOI: https://doi.org/10.1016/j.maturitas
8. Prilepskaya V.N. Genitourinary menopausal syndrome: the potential of estriol. Ginekologiya [Gynecology]. 2018; 20 (1): 5–8. DOI: https://doi.org/10.26442/2079-5696_20.1.5-8 (in Russian)
9. Palmaa F., Volpea A., Villa B., Cagnacci A. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: the AGATA study. Maturitas. 2016; 83: 40–4.
10. Sinha A., Ewies A.A.A. Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview. Climacteric. 2013; 16: 305–12.
11. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause. 2013; 20 (9): 888–902 DOI: https://doi.org/10.1097/gme.0b013e3182a122c2
12. Salvatore S., Nappi R.E., Zerbinati N., Calligaro A., Ferrero S., Origoni M., et al. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric. 2014; 17 (4): 363–9. DOI: https://doi.org/10.3109/13697137.2014.899347 Epub 2014 Jun 5. PMID: 24605832.
13. Apolikhina I.A., Kulikov I.A., Gorbunova E.A. Laser technologies are world leaders in aesthetic gynecology. Opinion Leader. 2018; (S2): 79–84. (in Russian)
14. Kulikov I.A., Apolikhina I.A., Spokoyny L.B. Possibilities of using neodymium laser (ND:YAG) in gynecology. Metamorfozy [Metamorphoses]. 2019; (26): 26–31. (in Russian)
15. Talybova A.P., Sten’ko A.G. The effectiveness of a neodymium (1064 nm) laser and fractional photothermolysis for the correction of the atrophic scars. Fizioterapiya, bal’neologiya i reabilitatsiya [Physiotherapy, balneology and rehabilitation]. 2017; 16 (4): 177–81. (in Russian)